Matches in Wikidata for { <http://www.wikidata.org/entity/Q65385476> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q65385476 description "assaig clínic" @default.
- Q65385476 description "clinical trial" @default.
- Q65385476 description "clinical trial" @default.
- Q65385476 description "clinical trial" @default.
- Q65385476 description "clinical trial" @default.
- Q65385476 description "ensaio clínico" @default.
- Q65385476 description "ensayo clínico" @default.
- Q65385476 description "ensayu clínicu" @default.
- Q65385476 description "essai clinique" @default.
- Q65385476 description "klinisch onderzoek" @default.
- Q65385476 description "клінічне випробування" @default.
- Q65385476 name "RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib" @default.
- Q65385476 name "RAD001 Plus Best Supportive Care" @default.
- Q65385476 type Item @default.
- Q65385476 label "RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib" @default.
- Q65385476 label "RAD001 Plus Best Supportive Care" @default.
- Q65385476 prefLabel "RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib" @default.
- Q65385476 prefLabel "RAD001 Plus Best Supportive Care" @default.
- Q65385476 P1050 Q65385476-D998FCE9-1DCD-4E65-B26B-D5DFC4489299 @default.
- Q65385476 P1132 Q65385476-2EE56E65-BE7F-4BBF-869B-D8BDF4505CBE @default.
- Q65385476 P1476 Q65385476-105A9898-05A3-4B17-B03D-D0B2AAB17790 @default.
- Q65385476 P17 Q65385476-03081A82-FEFD-498C-AA37-DCBF40345B47 @default.
- Q65385476 P17 Q65385476-3667D4E8-5627-4244-81E4-F50DE0CA7472 @default.
- Q65385476 P17 Q65385476-36D6BEE7-FDA2-447E-92FF-FEA1E705AB59 @default.
- Q65385476 P17 Q65385476-56E32FF5-2983-47D9-AD9B-D1C22BE604DD @default.
- Q65385476 P17 Q65385476-6C95EE39-AEFE-4A91-B533-7828FE6080C7 @default.
- Q65385476 P17 Q65385476-6DE21624-B4C4-4270-8B4B-824388602E33 @default.
- Q65385476 P17 Q65385476-9D8AF701-DB55-49F9-AF49-58EBF0844940 @default.
- Q65385476 P17 Q65385476-BF215181-CB71-40CE-A6F8-C2084FA966C8 @default.
- Q65385476 P17 Q65385476-D6928193-F23C-4328-9E97-BC391944EFEF @default.
- Q65385476 P17 Q65385476-D99BD698-E3A6-48FC-8527-66D007104A0E @default.
- Q65385476 P1813 Q65385476-1F47A897-6185-4F9E-BBDB-48B8E8D79223 @default.
- Q65385476 P2899 Q65385476-033A6579-712D-40EC-BDAA-6B9810617EEA @default.
- Q65385476 P3098 Q65385476-8250FA28-FC55-4A1F-B739-700BC062C90C @default.
- Q65385476 P31 Q65385476-FA700A1C-8197-4901-A118-65F50FC2E01A @default.
- Q65385476 P4135 Q65385476-1D69EE88-D383-494E-9BC7-D3E6B75F19A6 @default.
- Q65385476 P4844 Q65385476-576D40D9-7B69-4D9A-8EE6-DA5D80797657 @default.
- Q65385476 P580 Q65385476-196632DB-A874-4707-9425-AF9E85940284 @default.
- Q65385476 P582 Q65385476-20E4EFED-29BC-4A44-A0F6-70E8F86B9180 @default.
- Q65385476 P6099 Q65385476-F5FF7FD7-5383-4C75-B279-A82C5E798276 @default.
- Q65385476 P6153 Q65385476-EC1085B0-D345-41D8-B5E4-437025978EB7 @default.
- Q65385476 P8363 Q65385476-F23437B0-BCC8-4EBE-80FF-73724F3A3FE5 @default.
- Q65385476 P859 Q65385476-79BF8468-B578-4DF9-B417-EEE626116DA4 @default.
- Q65385476 P1050 Q33525 @default.
- Q65385476 P1132 "+416" @default.
- Q65385476 P1476 "A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Compare the Safety and Efficacy of RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed on VEGF Receptor Tyrosine Kinase Inhibitor" @default.
- Q65385476 P17 Q142 @default.
- Q65385476 P17 Q16 @default.
- Q65385476 P17 Q17 @default.
- Q65385476 P17 Q183 @default.
- Q65385476 P17 Q29 @default.
- Q65385476 P17 Q30 @default.
- Q65385476 P17 Q36 @default.
- Q65385476 P17 Q38 @default.
- Q65385476 P17 Q408 @default.
- Q65385476 P17 Q55 @default.
- Q65385476 P1813 "RECORD-1" @default.
- Q65385476 P2899 "+18" @default.
- Q65385476 P3098 "NCT00410124" @default.
- Q65385476 P31 Q30612 @default.
- Q65385476 P4135 "+85" @default.
- Q65385476 P4844 Q32089 @default.
- Q65385476 P580 "2006-11-01T00:00:00Z" @default.
- Q65385476 P582 "2008-02-01T00:00:00Z" @default.
- Q65385476 P6099 Q42824827 @default.
- Q65385476 P6153 Q507154 @default.
- Q65385476 P8363 Q78089383 @default.
- Q65385476 P859 Q507154 @default.